TESAMORELIN 5mg

for: Growth Hormone; Weight Loss; Lean Body Mass and Strength

Tesamorelin (5mg) is a specialized research reagent utilized primarily to investigate hypothalamic-pituitary-somatotropic signaling and the regulation of visceral adipose tissue metabolism. As a stabilized analog of the naturally occurring growth hormone-releasing hormone (GHRH), it is a potent agonist of the GHRH receptor (GHRHR). Dragon Pharma provides Tesamorelin 5mg at a purity level of 99%+, specifically for use in in-vitro laboratory experiments and preclinical animal models.

Overview

In the realm of metabolic research and endocrine signaling, few compounds offer as much utility as Tesamorelin. Known scientifically as a stabilized synthetic peptide containing the first 44 amino acids of human GHRH with an added trans-3-hexenoic acid group, this compound has become a fundamental tool for investigators exploring the reduction of visceral fat and the restoration of endogenous growth hormone pulses. Dragon Pharma provides Tesamorelin 5mg at a minimum purity of 99%, ensuring that researchers have access to a high-grade Research Peptide capable of producing reproducible and accurate data in complex metabolic models.

As scientific inquiry into lipodystrophy, metabolic syndrome, and cognitive decline expands, the need for reliable GHRH analogs like Tesamorelin has grown. This expanded profile examines the biochemical characteristics, structural integrity, and multifaceted research applications of Tesamorelin 5mg.

Molecular Characteristics and Chemical Profile

The structural integrity of Tesamorelin is what allows it to resist rapid enzymatic degradation by dipeptidyl peptidase-4 (DPP-4). The N-terminal modification significantly extends its biological half-life compared to native GHRH(1-44).

• Chemical Identity: Tesamorelin Acetate
• Molecular Formula: C221H366N72O67S
• Molecular Weight: 5135.9 g/mol
• Purity: >99% (HPLC and Mass Spectrometry verified)
• Form: Lyophilized powder
• Manufacturer: Dragon Pharma

Research Applications

The peptide is utilized in various scientific investigative domains, including:

• Lipid Metabolism: Mapping pathways involved in the reduction of visceral adipose tissue (VAT).
• Pituitary Signaling: Investigating the pulsatile release of endogenous growth hormone.
• Glucose Homeostasis: Studying the modulation of insulin sensitivity and carbohydrate metabolism.
• Cognitive Research: Evaluating the impact of GHRH analogs on proteostasis and neuroprotection in aging models.
• Inflammation: Studying the modulation of C-reactive protein (CRP) and systemic inflammatory markers.

Pathway and Mechanistic Context

The core value of Tesamorelin 5mg in a laboratory setting is its ability to manipulate the GHRH pathway without the desensitization often associated with exogenous growth hormone administration. In a natural physiological state, GHRH is released by the hypothalamus to stimulate the pituitary somatotrophs.

The GHRH-IGF-1 Signaling Axis

Upon activation by Tesamorelin, the GHRH receptor initiates a signal transduction cascade that stimulates the synthesis and secretion of growth hormone (GH). This endogenous GH then acts on various tissues to produce Insulin-like Growth Factor 1 (IGF-1).

Key Mechanistic Shifts:

• Lipolysis Stimulation: Tesamorelin facilitates the breakdown of visceral fat by increasing GH levels, which directly interacts with adipocyte receptors.
• Pulsatile Secretion: Unlike synthetic GH, Tesamorelin maintains the natural feedback loops, providing a framework for studying physiological hormone rhythms.
• Protein Accretion: By upregulating the IGF-1 axis, Tesamorelin conserves lean tissue mass during metabolic stress.

Primary Research Applications

1. Lipodystrophy and Visceral Adiposity Research

Tesamorelin is heavily utilized in studies involving abdominal fat accumulation and metabolic dysfunction. Because it specifically targets visceral fat rather than subcutaneous fat, it provides a unique framework for investigating the resolution of "central obesity" in research models.

2. Cognitive Decline and Neuroprotection

Known in research circles for its potential impact on brain health, Tesamorelin is used to observe how GHRH analogs influence GABA levels and cognitive performance. Investigators study changes in the clearing of proteotoxic aggregates in models of neurodegenerative disease.

3. Cardiovascular Metabolic Risk

In cardiovascular research, Tesamorelin is investigated for its potential to improve lipid profiles and reduce liver fat (steatosis). Research models focus on how the normalization of the somatotropic axis can improve overall heart health and vascular resilience.

Form and Analytical Testing

At Dragon Pharma, the commitment to scientific accuracy begins with the manufacturing process. Tesamorelin 5mg is produced under strict laboratory conditions to ensure that the compound remains stable and potent.

• Lyophilization for Stability: The compound is supplied in a lyophilized (freeze-dried) form. This process removes moisture while preserving the complex molecular structure, which is critical for maintaining a long shelf life.
• Rigorous Analytical Verification: To guarantee a purity level of 99% or higher, every batch undergoes High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to verify that the chemical signature matches the intended profile.

Product Usage Disclaimer: This product is intended for laboratory and in-vitro research use only. It is not approved for human or veterinary application. Must be handled by qualified professionals. Not for drug, food, or cosmetic purposes. Misuse or misbranding is strictly prohibited.

Author:

All information was searched/edited by Dr. S. Edwin, and Dr. E. Croft who holds a doctorate from Case Western Reserve University School of Medicine